Cingulate Therapeutics

Amendment
CIK: 0001593151·Pharmaceuticals·DELAWARE·Filed: Jan 16, 2018
Total Offering

Indefinite

Amount Sold

$6,800,000

Investors

116

First Sale

Nov 14, 2013

Offering Details

Type
Equity, Debt, Other: Membership Units
Exemptions
Rule 506(b), Section 4(a)(5)
Entity Type
Limited Liability Company
Non-Accredited Investors
No

Related Persons

NameRole
Louis George Van Horn
Related Person
Shane j Schaffer
Related Person
Craig Steven Gilgallon
Related Person
Matthew N Brams
Related Person
Raul R Silva
Related Person
Laurie A Myers
Related Person
Arthur B Straughn
Related Person
Patrick J Gallagher
Related Person

Company

Cingulate Therapeutics

6 SOUTH STREET

MORRISTOWN, NJ, 07960

862-260-9132

SEC Filing

0001593151-18-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Cingulate Therapeutics Form D Filing — Indefinite | FilingFlow